Viewing Study NCT04230759


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2025-12-26 @ 2:29 PM
Study NCT ID: NCT04230759
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2020-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
Sponsor: Goethe University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module